PRELIMINARY CLINICAL DATA IN THE PHASE 1/2A DOSE ESCALATION TRIAL OF RHENIUM (186RE) OBISBEMEDA (186RNL) IN LEPTOMENINGEAL METASTASES (LM): THE RESPECT-LM TRIAL

Authors
Category Primary study
JournalNeuro-Oncology Advances
Year 2023
This article has no abstract
Epistemonikos ID: 7fba65ef7ecdcd102e41a9647563c27ab459f889
First added on: Feb 19, 2025